Physician profile
Erica Lynn Melick
NPI 1255903662
$4,849.47
in general payments reported to CMS, 2019-2025
18 companies · $2,566 in 2025
The $2,566 reported for 2025 was more than what 97% of Clinical Nurse Specialist providers received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $209 · 2022: $555 · 2023: $941 · 2024: $578 · 2025: $2,566.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,619 · Travel and Lodging: $1,215 · Consulting Fee: $250 · Education: $1.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,618.53 |
| Travel and Lodging | $1,215.49 |
| Consulting Fee | $250.00 |
| Education | $1.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $2,150.83 | 2022-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Pascal |
| Abiomed | $398.37 | 2022-2024 | Impella |
| Medtronic, INC. | $389.83 | 2022-2025 | Selectsecure, Mycarelink, Aurora Ev-Icd Mri Surescan |
| E.R. Squibb & Sons, L.L.C. | $363.27 | 2023-2025 | Camzyos |
| Alnylam Pharmaceuticals INC. | $288.53 | 2024-2025 | Amvuttra, Onpattro |
| Astrazeneca Pharmaceuticals Lp | $275.36 | 2022-2024 | Wainua, Farxiga, Andexxa |
| Shockwave Medical, INC | $226.15 | 2022-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Amgen INC. | $187.34 | 2022-2024 | Repatha, Tezspire |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $164.17 | 2021-2025 | Lifevest |
| Esperion Therapeutics, INC. | $84.92 | 2021 | |
| Novartis Pharmaceuticals Corporation | $79.87 | 2023-2024 | |
| Kowa Pharmaceuticals America, INC. | $78.52 | 2021-2022 | |
| Amarin Pharma, INC. | $50.78 | 2021-2022 | |
| Pfizer INC. | $35.00 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.38 | 2023 | Jardiance |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Irhythm Technologies, INC. | $20.32 | 2023 | Zio Xt Patch |
| Cashflow Solutions, LLC | $16.46 | 2023 | Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White |
| Janssen Pharmaceuticals, INC | $16.37 | 2023 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erica Melick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.